Roche

@Roche

We advance science so that we all have more time with the people we love. Read our community guidelines: go.roche.com/CG

Basel, Switzerland

Roche
@Roche
Aug 28
#MEDIA – At #APVRS2026, we're pleased to share new two-year data for our treatment in patients with PCV, a severe sub-type of nAMD – the leading cause of vision loss in people over 60. roche.com/media
Roche
@Roche
Aug 17
Sleep should be a time of rest, not a time of risk. "I think predictive technology gives us a lot more than just a safe sleep and better predictions. It also means more quality of life and not using this energy for the diabetes, but actually using it for things that matter to
5
Roche
@Roche
Jul 24
#MEDIA – We are pleased to share that the CHMP has recommended approval of our continuous delivery treatment for adults with neovascular age-related macular degeneration (#nAMD) - the leading cause of blindness in people over 60. 👉 spkl.io/60127J2hs
5
Roche
@Roche
Jul 23
Roche continues strong momentum with 6% sales growth (CER) in the first half of 2026 – full-year outlook confirmed. For more details on our performance, click here ➡️ spkl.io/60137JsLP
3
Roche
@Roche
Jul 20
Roche’s sequencing by expansion (SBX) technology is transforming DNA sequencing! By converting nucleotide bases into long molecules before it passes through microscopic pores, it scales up molecular signals into digital data.✨ #Biotech #Innovation go.roche.com/xnanosbx
6